Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic Disorders
- Sponsor
- Hospices Civils de Lyon
- Study ID
- NCT07573046
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alzheimer's Disease
- People Without Neurocognitive Disorder
- Progressive Primary Aphasia Semantic Variant
- Vascular Neurocognitive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- ExéSem cognitive battery — DIAGNOSTIC_TESTThe ExéSem battery is a neuropsychological assessment tool designed to evaluate semantic processing and the contribution of executive control in patients with or without neurocognitive disorders. It consists of three tasks: (1) a dual task combining semantic judgment and semantic matching using identical items, (2) a word-to-picture matching task, and (3) a rapid naming task. Each task is structured to manipulate the level of executive demand required to access semantic representations. This variation allows the identification of whether semantic difficulties remain stable or worsen under increased executive load, thereby distinguishing primary semantic deficits from executive-related semantic impairments. The battery is administered by a trained professional using standardized instructions and requires approximately 30 minutes to complete. It is used for diagnostic and research purposes only and does not involve any therapeutic intervention.
Study Details
This protocol describes a study aimed at evaluating the psychometric properties of the ExéSem battery, developed to differentiate semantic deficits from executive semantic impairments in patients with post-lesional or neurodegenerative anomia. Currently available tools do not allow a straightforward distinction between these deficits, limiting diagnostic accuracy and clinical management. The ExéSem battery was developed through a collaboration between Hospices Civils de Lyon, the University of Mons, and Laval University to address this gap. The battery includes three main tasks: (1) a dual task combining semantic judgment and semantic matching using identical items, (2) a word-picture matching task, and (3) a rapid naming task. Each task is designed to manipulate the level of executive control required to access semantic representations. This allows the identification of whether performance declines under increased executive demand, thereby distinguishing executive-related semantic impairments.
Key Dates
- First listed
- May 7, 2026
- Start date
- Sep 9, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2029
- Completion
- Sep 9, 2029
Study Design
- Enrollment
- 140 participants (estimated)
Arms
- Arm: Participants without cognitive impairmentParticipanst with a MoCA score greater than or equal to 26/30 and a score greater than the alert threshold based on age and education level on the DTLA scale. Participants who have never received a diagnosis of cognitive impairment.
- Arm: Participants with Cognitive ImpairmentParticipants receiving memory clinic care with a diagnosis of Alzheimer's disease, at the stage of minor or major neurocognitive impairment, according to the 2011 NIA-AA criteria, or with a diagnosis of vascular neurocognitive impairment according to the VasCog-2-WSO diagnostic criteria , or with a diagnosis of primary progressive aphasia with semantic variant. Participants with a Mini-Mental State Examination (MMSE) score ≥ 20/30, within the 6 months preceding enrollment;
Primary Outcome Measure
Score obtained on the ExéSem battery [ Time Frame: At enrollment ]
Find similar trials
Related Studies
- Wisconsin Brain Donor ProgramEnrolling By Invitation · University of Wisconsin, Madison · Madison, Wisconsin
- Dominantly Inherited Alzheimer Network (DIAN)Recruiting · Washington University School of Medicine · Jacksonville, Florida
- Imaging of Brain Amyloid Plaques in the Aging PopulationPHASE4 · Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into StudiesRecruiting · Banner Health · Phoenix, Arizona